OptimizeRx Corp (OPRX) Insider Trading -- Recent Executive & Director Transactions

14 insiders reported 73 Form 4 transactions for OptimizeRx Corp (OPRX) over the past 18 months (most recent 2026-06-10). Recent activity: KLEMA CATHY (Director) Buy 34,517 shares, WASSON GREGORY D (Director) Buy 34,517 shares, Spangler Patrick D (Director) Buy 34,517 shares, Vos Ellen O'Connor (Director) Buy 34,517 shares, Lang James Paul (Director) Buy 34,517 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-06-10KLEMA CATHYDirectorBuy34,517$0
2026-06-10WASSON GREGORY DDirectorBuy34,517$0
2026-06-10Spangler Patrick DDirectorBuy34,517$0
2026-06-10Vos Ellen O'ConnorDirectorBuy34,517$0
2026-06-10Lang James PaulDirectorBuy34,517$0
2026-06-10Presti Mariyamma VargheseDirectorBuy13,060$0
2026-06-10Presti Mariyamma VargheseDirectorBuy17,258$0
2026-05-18Silvestro Stephen LChief Executive OfficerSell5,219$27,191
2026-05-18Greco TheresaChief Commercial OfficerSell914$4,762
2026-05-18Greco TheresaChief Commercial OfficerSell879$4,580
2026-02-13Odence-Ford MarionChief Legal & Admin OfficerBuy4,000$0
2026-02-13Odence-Ford MarionChief Legal & Admin OfficerSell1,386$12,793
2025-12-23Odence-Ford MarionChief Legal & Admin OfficerSell4,051$51,610
2025-12-23Silvestro Stephen LChief Executive OfficerSell3,361$42,819
2025-12-23Besch DougChief Product & Tech OfficerSell4,079$51,966
2025-12-23Silvestro Stephen LChief Executive OfficerSell3,361$42,819
2025-12-23Greco TheresaChief Commercial OfficerSell1,420$18,091
2025-12-23Stelmakh EdwardChief Finance & Strat OfficerBuy5,237$0
2025-12-23Stelmakh EdwardChief Finance & Strat OfficerSell1,388$18,752
2025-12-23Stelmakh EdwardChief Finance & Strat OfficerSell3,658$46,603
2025-12-22Besch DougChief Product & Tech OfficerBuy1,964$0
2025-12-22Besch DougChief Product & Tech OfficerSell581$7,849
2025-12-22D'Silva Andrew J.Chief Business OfficerSell703$9,498
2025-12-22Odence-Ford MarionChief Legal & Admin OfficerBuy3,928$0
2025-12-22Odence-Ford MarionChief Legal & Admin OfficerSell1,153$15,577

Source: SEC Form 4 filings · as of 2026-06-10